Clinically, CTD-ILD/IPAF are more often treated with systemic corticosteroids and other immunosuppressants that suppress airway iNOS and lower FeNO [40,41,42], whereas IPF is typically managed with antifibrotics without maintenance immunosuppression. This evidence concerns the gene NOS2 and idiopathic interstitial pneumonia.